Editorial label review
Hims & Hers Menopause side effects: insomnia
Primary formulary: Estradiol (oral, patch, vaginal) + micronized progesterone; paroxetine as non-HRT option
Quick answer
Insomnia shows up on the FDA labels for the active ingredients Hims & Hers Menopause prescribes — Estradiol (oral, patch, vaginal) + micronized progesterone. This page walks through the labelled frequency ranges, what to watch for, and when to call your clinician.
What Hims & Hers Menopause prescribes and why it matters for insomnia
Hims & Hers Menopause prescribes FDA-approved estradiol in oral, patch, and vaginal forms plus micronized progesterone, with low-dose paroxetine available as a non-hormonal option. Because Hims & Hers Menopause prescribes FDA-approved active ingredients, the labelled adverse-reaction tables from those medications describe the frequencies you should expect. Paroxetine (Brisdelle) carries the highest label-level insomnia signal across these programmes.
Common label-level side effects
Sourced from Section 6 (Adverse Reactions) of each FDA-approved PIL.
- Insomnia is listed at 2–6% in Section 6 of most estradiol PIL adverse-reaction tables
- Brisdelle (paroxetine 7.5 mg) PIL lists insomnia at 15–20% — a Midi and Hims & Hers non-HRT consideration
- Fezolinetant (Veozah) PIL lists insomnia at low frequency in Section 6
Serious label-level warnings
Drawn from Section 5 (Warnings and Precautions) of the FDA-approved PILs — including the estradiol boxed warning where applicable.
- Insomnia with rapidly worsening depression or new suicidal thoughts on paroxetine — FDA class boxed warning applies
- Insomnia paired with chest pain or palpitations — cardiovascular signals on the estradiol boxed warning
When to contact your clinician
Contact your clinician if insomnia is paired with new suicidal thoughts on paroxetine, or with chest symptoms on estradiol — both labels require prompt review.
Call 911 if you develop chest pain, one-sided weakness, sudden severe headache, vision or speech change, or shortness of breath — per the estradiol PIL boxed warning for cardiovascular events.
What to ask your provider
- “Which SKU in the Hims & Hers Menopause formulary am I on, and what is its labelled frequency for insomnia?”
- “Is my insomnialikely a labelled adverse reaction, or something separate that needs its own workup?”
- “Would a different delivery route (patch vs. pill, oral vs. transdermal) change my expected frequency?”
- “What is the plan if insomniadoes not settle within 2–3 cycles?”
Related editorial reading
- Full editorial review of Hims & Hers Menopause — formulary, pricing, and clinician model.
- Is insomnia caused by menopause itself? — how the transition presents on its own.
- Estradiol medication page — mechanism, dosing, and full PIL notes.
- Paroxetine low dose medication page — secondary ingredient in Hims & Hers Menopause's formulary.
- Browse all side-effect matrix pages — 4 brands × 15 symptoms.
Frequently asked questions
- How often does insomnia happen on Hims & Hers Menopause?
- Hims & Hers Menopause's primary regimen — Estradiol (oral, patch, vaginal) + micronized progesterone; paroxetine as non-HRT option — carries the FDA-labelled adverse-reaction frequencies for insomnia described on this page. Ranges vary from < 1% to 45% depending on the specific active ingredient and delivery route. See the sources block for the exact PIL tables.
- When should I stop Hims & Hers Menopause because of insomnia?
- Talk to your clinician immediately if you meet any of the "when to contact" criteria on this page — most estradiol PIL Section 5 warnings require prompt reassessment. Do not stop hormone therapy without medical input; abrupt discontinuation can trigger rebound symptoms.
- Is insomnia on the FDA label for Hims & Hers Menopause's medications?
- Paroxetine (Brisdelle) carries the highest label-level insomnia signal across these programmes.
- Is insomnia caused by menopause itself?
- Insomnia can appear during the menopause transition for reasons unrelated to hormone therapy. Our /does-menopause-cause/insomnia explainer covers what the underlying biology is and how clinicians disentangle the transition from the treatment.